CheckMate 743: A Glimmer of Hope for Malignant Pleural Mesothelioma

Clin Lung Cancer. 2021 Mar;22(2):71-73. doi: 10.1016/j.cllc.2020.11.009. Epub 2020 Dec 2.
No abstract available

Keywords: CheckMate 743; Immune checkpoint; Immunotherapy; Malignant pleural mesothelioma; Mesothelioma.

MeSH terms

  • Clinical Trials as Topic
  • Humans
  • Immune Checkpoint Inhibitors / therapeutic use
  • Immunotherapy
  • Ipilimumab / therapeutic use
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / pathology
  • Mesothelioma, Malignant / drug therapy*
  • Mesothelioma, Malignant / pathology
  • Nivolumab / therapeutic use
  • Pleural Neoplasms / drug therapy*
  • Pleural Neoplasms / pathology
  • Treatment Outcome

Substances

  • Immune Checkpoint Inhibitors
  • Ipilimumab
  • Nivolumab

Associated data

  • ClinicalTrials.gov/NCT04334759
  • ClinicalTrials.gov/NCT02784171
  • ClinicalTrials.gov/NCT03762018
  • ClinicalTrials.gov/NCT02709512